Back to top

Analyst Blog

Zacks Equity Research

3M Set to Acquire Ceradyne

MMM

 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

3M Company (MMM - Analyst Report) recently announced its intention of acquiring Ceradyne Inc. , a global leader in the development and production of advanced technical ceramics, for $35 a share. The transaction is estimated at $860 million or $670 million net of cash, cash equivalents, short-term investments and debt.

As per the terms of the agreement, a subsidiary of 3M is expected to initiate a tender offer for the purchase of all outstanding shares of Ceradyne within a period of 10 days. The offer will be subject to the tender of a majority of Ceradyne’s shares and other regulatory closing conditions. The deal is expected to be completed by the end of this year.

With the acquisition of Ceradyne, 3M is expected to develop new technologies and innovation for specifically designed materials requiring advanced ceramics. Post acquisition, Ceradyne will be integrated into the Energy and Advanced Materials division.

3M expects the transaction to be accretive to its earnings by one cent in the very first year, on pro forma basis. On a GAAP basis, the acquisition is expected to be accretive to earnings by 5 cents.

Based in Costa Mesa, California and with operations in the U.S., Canada, China and Germany, Ceradyne reported annual revenue of approximately $500 million. The company is a global leader in the development and production of advanced technical ceramics for demanding applications in the automotive, oil and gas, solar, industrial, electronics and defense industries. Therefore, this acquisition is a strategic fit with 3M’s existing transportation, energy markets and defense businesses.  

The 3M brand is recognized around the world. Household names like Nexcare, Post-it, Scotch, Scotch-Brite and Scotchgard are market leaders. The company remains focused on new product development, with its scientists and innovators enjoying an important competitive advantage worldwide. The company currently has a Zacks #3 Rank, implying a short-term Hold rating on the stock.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%